Gossamer Bio Inc expected to post a loss of 26 cents a share - Earnings Preview

Gossamer Bio

31/10/2023 02:06

* Gossamer Bio Inc  GOSS.OQ   GOSS.O  is expected to show no
change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Gossamer Bio Inc is
for a
loss of 26 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $4​, above​ its last closing price of $0.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.48       -0.49      -0.45     Beat    8
 Mar. 31 2023  -0.52       -0.53      -0.52     Beat    1.8
 Dec. 31 2022  -0.62       -0.62      -0.59     Beat    5.3​
 Sep. 30 2022  -0.66       -0.64      -0.65     Missed  -2.3
 ​​Jun.        -0.68       -0.70      -0.74     Missed  -5.8
 30 2022                                                
 Mar. 31 2022  -0.77       -0.77      -0.76     Beat    0.9​
 Dec. 31 2021  -0.74       -0.74      -0.74     Met     0.4
 Sep. 30 2021  -0.78       -0.78      -0.80     Missed  -1.9
 This summary was machine generated October 31 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated